392 related articles for article (PubMed ID: 7474123)
1. Mutagenic analysis of human immunodeficiency virus type 1 Vpr: role of a predicted N-terminal alpha-helical structure in Vpr nuclear localization and virion incorporation.
Yao XJ; Subbramanian RA; Rougeau N; Boisvert F; Bergeron D; Cohen EA
J Virol; 1995 Nov; 69(11):7032-44. PubMed ID: 7474123
[TBL] [Abstract][Full Text] [Related]
2. Mutational analysis of cell cycle arrest, nuclear localization and virion packaging of human immunodeficiency virus type 1 Vpr.
Di Marzio P; Choe S; Ebright M; Knoblauch R; Landau NR
J Virol; 1995 Dec; 69(12):7909-16. PubMed ID: 7494303
[TBL] [Abstract][Full Text] [Related]
3. Nuclear import, virion incorporation, and cell cycle arrest/differentiation are mediated by distinct functional domains of human immunodeficiency virus type 1 Vpr.
Mahalingam S; Ayyavoo V; Patel M; Kieber-Emmons T; Weiner DB
J Virol; 1997 Sep; 71(9):6339-47. PubMed ID: 9261351
[TBL] [Abstract][Full Text] [Related]
4. Mutagenesis of the putative alpha-helical domain of the Vpr protein of human immunodeficiency virus type 1: effect on stability and virion incorporation.
Mahalingam S; Khan SA; Murali R; Jabbar MA; Monken CE; Collman RG; Srinivasan A
Proc Natl Acad Sci U S A; 1995 Apr; 92(9):3794-8. PubMed ID: 7731985
[TBL] [Abstract][Full Text] [Related]
5. A leucine triplet repeat sequence (LXX)4 in p6gag is important for Vpr incorporation into human immunodeficiency virus type 1 particles.
Lu YL; Bennett RP; Wills JW; Gorelick R; Ratner L
J Virol; 1995 Nov; 69(11):6873-9. PubMed ID: 7474102
[TBL] [Abstract][Full Text] [Related]
6. Identification of residues in the N-terminal acidic domain of HIV-1 Vpr essential for virion incorporation.
Mahalingam S; Khan SA; Jabbar MA; Monken CE; Collman RG; Srinivasan A
Virology; 1995 Feb; 207(1):297-302. PubMed ID: 7871742
[TBL] [Abstract][Full Text] [Related]
7. Incorporation of Vpr into human immunodeficiency virus type 1: role of conserved regions within the P6 domain of Pr55gag.
Checroune F; Yao XJ; Göttlinger HG; Bergeron D; Cohen EA
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Sep; 10(1):1-7. PubMed ID: 7648278
[TBL] [Abstract][Full Text] [Related]
8. The putative alpha helix 2 of human immunodeficiency virus type 1 Vpr contains a determinant which is responsible for the nuclear translocation of proviral DNA in growth-arrested cells.
Nie Z; Bergeron D; Subbramanian RA; Yao XJ; Checroune F; Rougeau N; Cohen EA
J Virol; 1998 May; 72(5):4104-15. PubMed ID: 9557700
[TBL] [Abstract][Full Text] [Related]
9. Incorporation of Vpr into human immunodeficiency virus type 1 requires a direct interaction with the p6 domain of the p55 gag precursor.
Bachand F; Yao XJ; Hrimech M; Rougeau N; Cohen EA
J Biol Chem; 1999 Mar; 274(13):9083-91. PubMed ID: 10085158
[TBL] [Abstract][Full Text] [Related]
10. Biochemical mechanism of HIV-I Vpr function. Specific interaction with a cellular protein.
Zhao LJ; Mukherjee S; Narayan O
J Biol Chem; 1994 Jun; 269(22):15577-82. PubMed ID: 8195203
[TBL] [Abstract][Full Text] [Related]
11. Human immunodeficiency virus type 1 Vpr localization: nuclear transport of a viral protein modulated by a putative amphipathic helical structure and its relevance to biological activity.
Subbramanian RA; Yao XJ; Dilhuydy H; Rougeau N; Bergeron D; Robitaille Y; Cohen EA
J Mol Biol; 1998 Apr; 278(1):13-30. PubMed ID: 9571031
[TBL] [Abstract][Full Text] [Related]
12. HIV-1 Vpr-chloramphenicol acetyltransferase fusion proteins: sequence requirement for virion incorporation and analysis of antiviral effect.
Yao XJ; Kobinger G; Dandache S; Rougeau N; Cohen E
Gene Ther; 1999 Sep; 6(9):1590-9. PubMed ID: 10490769
[TBL] [Abstract][Full Text] [Related]
13. The p6gag domain of human immunodeficiency virus type 1 is sufficient for the incorporation of Vpr into heterologous viral particles.
Kondo E; Mammano F; Cohen EA; Göttlinger HG
J Virol; 1995 May; 69(5):2759-64. PubMed ID: 7707498
[TBL] [Abstract][Full Text] [Related]
14. Functional analysis of HIV-1 Vpr: identification of determinants essential for subcellular localization.
Mahalingam S; Collman RG; Patel M; Monken CE; Srinivasan A
Virology; 1995 Oct; 212(2):331-9. PubMed ID: 7571402
[TBL] [Abstract][Full Text] [Related]
15. Functional role of residues corresponding to helical domain II (amino acids 35 to 46) of human immunodeficiency virus type 1 Vpr.
Singh SP; Tomkowicz B; Lai D; Cartas M; Mahalingam S; Kalyanaraman VS; Murali R; Srinivasan A
J Virol; 2000 Nov; 74(22):10650-7. PubMed ID: 11044109
[TBL] [Abstract][Full Text] [Related]
16. Arginine residues in the C-terminus of HIV-1 Vpr are important for nuclear localization and cell cycle arrest.
Zhou Y; Lu Y; Ratner L
Virology; 1998 Mar; 242(2):414-24. PubMed ID: 9514978
[TBL] [Abstract][Full Text] [Related]
17. A conserved LXXLF sequence is the major determinant in p6gag required for the incorporation of human immunodeficiency virus type 1 Vpr.
Kondo E; Göttlinger HG
J Virol; 1996 Jan; 70(1):159-64. PubMed ID: 8523520
[TBL] [Abstract][Full Text] [Related]
18. The carboxy-terminal domain is essential for stability and not for virion incorporation of HIV-1 Vpr into virus particles.
Mahalingam S; Patel M; Collman RG; Srinivasan A
Virology; 1995 Dec; 214(2):647-52. PubMed ID: 8553570
[TBL] [Abstract][Full Text] [Related]
19. p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease.
Huang M; Orenstein JM; Martin MA; Freed EO
J Virol; 1995 Nov; 69(11):6810-8. PubMed ID: 7474093
[TBL] [Abstract][Full Text] [Related]
20. Role of the conserved dipeptide Gly75 and Cys76 on HIV-1 Vpr function.
Mahalingam S; Collman RG; Patel M; Monken CE; Srinivasan A
Virology; 1995 Jul; 210(2):495-500. PubMed ID: 7618286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
